You are here

Article info

Article menu
Emerging technologies, pharmacology and therapeutics
Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms

Authors

  1. Correspondence to Dr Darren M Riddy; darren.riddy{at}monash.edu; Professor Christopher J Langmead; chris.langmead{at}monash.edu
View Full Text

Citation

Riddy DM, Kammoun HL, Murphy AJ, et al
Deletion of GPR21 improves glucose homeostasis and inhibits the CCL2-CCR2 axis by divergent mechanisms
BMJ Open Diabetes Research and Care 2021;9:e002285. doi: 10.1136/bmjdrc-2021-002285

Publication history

  • Received March 22, 2021
  • Accepted October 25, 2021
  • First published November 15, 2021.
Online issue publication 
May 15, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.